Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console

First ever imaging system that incorporates phased Array IVUS, Rotational
IVUS and integrated FFR all onto a single platform, providing Physicians
and Administrators Choice

SAN DIEGO, Feb. 7 /PRNewswire-FirstCall/ -- Volcano Corporation
(Nasdaq: VOLC), a leading manufacturer of intravascular ultrasound (IVUS)
and functional measurement (FM) technology, announced today FDA 510(k)
clearance of the s5-Revo and s5-FFR (fractional flow reserve) options.
These two new product offerings now enable rotational IVUS and FFR to
operate on the same integrated Volcano s5 Imaging System as Volcano's
previous line of phased array IVUS catheters and functionality. For the
first time, physicians can choose among three powerful diagnostic tools --
all on the same integrated IVUS platform.

PR Newswire